Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2016-03-09 (10 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: VIENNE (38200), Isere
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
GRANDE PHARMACIE DE L'ISLE : revenue, balance sheet and financial ratios
GRANDE PHARMACIE DE L'ISLE is a French company
founded 10 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in VIENNE (38200),
this company of category PME
shows in 2024 a net income positive of 132 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - GRANDE PHARMACIE DE L'ISLE (SIREN 818960080)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
131 812 €
105 467 €
158 029 €
138 549 €
132 823 €
126 420 €
87 510 €
50 095 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, GRANDE PHARMACIE DE L'ISLE generates positive net income of 132 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2024: 50 k€ -> 132 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
131 812 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 107%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 42%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
106.689%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
41.546%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution GRANDE PHARMACIE DE L'ISLE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
626.721
427.941
288.692
201.42
148.531
106.331
106.714
106.689
Financial autonomy
12.836
17.344
23.535
29.499
35.161
40.781
42.43
41.546
Repayment capacity
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
106.692024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average+5 pts over 3 years
In 2024, the debt ratio of GRANDE PHARMACIE DE L'ISLE (106.69) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
41.55%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average
In 2024, the financial autonomy of GRANDE PHARMACIE DE L'ISLE (41.5%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 213.03. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
213.035
Liquidity indicators evolution GRANDE PHARMACIE DE L'ISLE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
208.846
169.864
195.101
184.922
193.564
176.531
200.083
213.035
Interest coverage
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
213.032024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Good+20 pts over 3 years
In 2024, the liquidity ratio of GRANDE PHARMACIE DE L'ISLE (213.03) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of GRANDE PHARMACIE DE L'ISLE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of GRANDE PHARMACIE DE L'ISLE is estimated at
1 840 192 €
(range 1 281 481€ - 2 753 033€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1281k€1840k€2753k€
1 840 192 €Range: 1 281 481€ - 2 753 033€
NAF 5 année 2024
Valuation method used
Net Income Multiple
131 812 €
×
14.0x
=1 840 193 €
Range: 1 281 481€ - 2 753 034€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare GRANDE PHARMACIE DE L'ISLE with other companies in the same sector:
Frequently asked questions about GRANDE PHARMACIE DE L'ISLE
What is the revenue of GRANDE PHARMACIE DE L'ISLE ?
The revenue of GRANDE PHARMACIE DE L'ISLE is not publicly disclosed (confidential accounts filed with INPI).
Is GRANDE PHARMACIE DE L'ISLE profitable?
Yes, GRANDE PHARMACIE DE L'ISLE generated a net profit of 132 k€ in 2024.
Where is the headquarters of GRANDE PHARMACIE DE L'ISLE ?
The headquarters of GRANDE PHARMACIE DE L'ISLE is located in VIENNE (38200), in the department Isere.
Where to find the tax return of GRANDE PHARMACIE DE L'ISLE ?
The tax return of GRANDE PHARMACIE DE L'ISLE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does GRANDE PHARMACIE DE L'ISLE operate?
GRANDE PHARMACIE DE L'ISLE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart